PE34998A1 - Un atomizador nasal que contiene un esteroide intranasal y un antihistaminico - Google Patents

Un atomizador nasal que contiene un esteroide intranasal y un antihistaminico

Info

Publication number
PE34998A1
PE34998A1 PE00092996A PE00092996A PE34998A1 PE 34998 A1 PE34998 A1 PE 34998A1 PE 00092996 A PE00092996 A PE 00092996A PE 00092996 A PE00092996 A PE 00092996A PE 34998 A1 PE34998 A1 PE 34998A1
Authority
PE
Peru
Prior art keywords
antihistamine
anticolynergic
mixtures
atomizer containing
nasal atomizer
Prior art date
Application number
PE00092996A
Other languages
English (en)
Inventor
Ronald Dean Cramer
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE34998A1 publication Critical patent/PE34998A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA COMPOSICION, QUE COMPRENDE: a) UN GLUCOCORTICOIDE SELECCIONADO DE BECLOMETASONA, FLUNISOLIDA, TRIAMCINOLONA, FLUTICASONA, MOMETASONA, BUDESONIDA O MEZCLAS DE ESTOS; b) UN ANTIHISTAMINICO INHIBIDOR DE LEUCOTRIENO SELECCIONADO DE CETIRIZINA, LORATADINA, AZELASTINA O MEZCLAS DE ESTOS; c) UN VEHICULO INTRANASAL Y, OPCIONALMENTE, PUEDE CONTENER UNA AMINA SIMPATICOMIMETICA, UN AGENTE ANTIINFLAMATORIO NO ESTEROIDEO, UN INHIBIDOR O ANTAGONISTA DE LIPOXIGENASA, UN ANALGESICO NO OPIATO, UN ANTICOLINERGICO, UN MUCOLITICO O UN ANTIALERGICO ENTRE OTROS. SIENDO UTIL EN EL TRATAMIENTO DE LOS SINTOMAS DE RINOCONJUNTIVITIS ESTACIONAL O CONTINUA
PE00092996A 1995-12-19 1996-12-18 Un atomizador nasal que contiene un esteroide intranasal y un antihistaminico PE34998A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57479195A 1995-12-19 1995-12-19

Publications (1)

Publication Number Publication Date
PE34998A1 true PE34998A1 (es) 1998-07-24

Family

ID=24297657

Family Applications (1)

Application Number Title Priority Date Filing Date
PE00092996A PE34998A1 (es) 1995-12-19 1996-12-18 Un atomizador nasal que contiene un esteroide intranasal y un antihistaminico

Country Status (4)

Country Link
EP (1) EP0780127A1 (es)
AR (1) AR005138A1 (es)
CO (1) CO4780018A1 (es)
PE (1) PE34998A1 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849263A (en) * 1993-03-30 1998-12-15 Charlotte-Mecklenburg Hospital Authority Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
US7214683B1 (en) 1994-12-30 2007-05-08 Sepracor Inc. Compositions of descarboethoxyloratadine
US7211582B1 (en) 1994-12-30 2007-05-01 Sepracor Inc. Methods for treating urticaria using descarboethoxyloratadine
EP0954318A1 (en) * 1996-06-04 1999-11-10 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
SE9604486D0 (sv) * 1996-12-05 1996-12-05 Astra Ab Novel formulation
FR2756739B1 (fr) * 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
AU6878098A (en) * 1997-04-30 1998-11-24 Warner-Lambert Company Topical nasal antiinflammatory compositions
EP1041990B1 (en) * 1997-12-23 2006-06-28 Schering Corporation Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
GB9806937D0 (en) 1998-03-31 1998-05-27 Procter & Gamble A spray device
US6248308B1 (en) 1998-04-14 2001-06-19 Sepracor Inc. Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma
AU2003204684B2 (en) * 1998-04-14 2005-11-24 Sepracor, Inc. Methods and compositions using cetrizine in compostion with leukotriene inhibitors for treating conditions responsive to leukotriene inhibition
US6384038B1 (en) 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
AR022378A1 (es) * 1998-09-10 2002-09-04 Schering Corp Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
EP1020233A1 (en) 1999-01-13 2000-07-19 The Procter & Gamble Company Dosing and delivering system
AU3065299A (en) * 1999-03-01 2000-09-21 Schering Corporation Compositions and methods for treating atopic dermatitis, angioedema and other disorders using antihistamines and glucocorticoids
GB9918559D0 (en) * 1999-08-07 1999-10-06 Glaxo Wellcome Kk Novel pharmaceutical formulation
JP2003511417A (ja) * 1999-10-08 2003-03-25 シェーリング コーポレイション 局所的鼻疾患治療
DE10064950A1 (de) * 2000-12-23 2002-07-11 Impetus Ag Basel Thixotropes Nasenspray
SI1446119T1 (sl) 2001-09-18 2006-08-31 Nycomed Danmark Aps Sestavki, ki obsegajo ipratorij in ksilometazolin, za zdravljenje obicajnega prehlada
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
CN1674916A (zh) 2002-08-30 2005-09-28 奥坦纳医药公司 环缩松与抗组胺药的组合用于治疗变应性鼻炎的用途
US7815924B2 (en) 2002-09-20 2010-10-19 Fmc Corporation Cosmetic composition containing microcrystalline cellulose
WO2004082589A2 (en) * 2003-03-20 2004-09-30 Ranbaxy Laboratories Limited Nasally administrable, bioavailable pharmaceutical composition of loratadine
US20050192261A1 (en) * 2003-09-15 2005-09-01 Jost-Price Edward R. Methods and reagents for the treatment of immunoinflammatory disorders
DK2522365T3 (en) * 2004-11-24 2017-02-06 Meda Pharmaceuticals Inc Compositions comprising azelastine and methods for its use
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
BRPI0609700A2 (pt) 2005-03-23 2010-04-20 Elan Pharma Int Ltd formulações de corticosteróide nanoparticulado e antihistamina
WO2008070264A2 (en) * 2006-10-10 2008-06-12 Case Western Reserve University Nasal spray composition and method for treating rhinitis, sinusitis or both
WO2011141929A2 (en) 2010-05-11 2011-11-17 Cadila Healthcare Limited Aqueous pharmaceutical compositions of fluticasone and olopatadine
RU2543326C2 (ru) * 2012-08-21 2015-02-27 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения зуда кожи
US9962397B2 (en) 2014-04-16 2018-05-08 John T. Given Intranasal medication delivery device and method of use thereof
US11135155B2 (en) 2014-07-08 2021-10-05 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
CN107929738A (zh) * 2017-11-28 2018-04-20 贵州云峰药业有限公司 一种含盐酸氮卓斯汀的组合物
WO2022098319A1 (en) * 2020-11-09 2022-05-12 Pharmactive Ilac Sanayi Ve Ticarey A.S. Pharmaceutical compositions comprising azelastine, beclomethasone and relevant excipients

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136163A (en) 1971-02-04 1979-01-23 Wilkinson Sword Limited P-menthane carboxamides having a physiological cooling effect
GB1421743A (en) 1972-04-18 1976-01-21 Wilkinson Sword Ltd Ingestible topical and other compositions
ZA821577B (en) 1981-04-06 1983-03-30 Boots Co Plc Therapeutic agents
JPS5888334A (ja) 1981-11-20 1983-05-26 Takasago Corp ３−ｌ−メントキシプロパン−１、２−ジオ−ル
US4767612A (en) 1987-01-23 1988-08-30 Rorer Pharmaceutical Corporation Triamcinolone acetonide for the treatment of allergic rhinitis
US4873259A (en) 1987-06-10 1989-10-10 Abbott Laboratories Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds
EP0318093A3 (en) 1987-11-25 1990-12-05 Merck Frosst Canada Inc. Diarylquinoline diacids and their use as medicaments
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use

Also Published As

Publication number Publication date
AR005138A1 (es) 1999-04-14
CO4780018A1 (es) 1999-05-26
EP0780127A1 (en) 1997-06-25

Similar Documents

Publication Publication Date Title
PE34998A1 (es) Un atomizador nasal que contiene un esteroide intranasal y un antihistaminico
DK1719512T3 (da) Sarsasapogenin og smilagenin til behandling af cognitive dysfunktioner
CY1109212T1 (el) Φαρμακευτικες συνθεσεις για την θεραπεια του ασθμα
AR025923A1 (es) Nueva combinacion de loteprednol y antihistaminicos
HUP0202311A2 (hu) Aeroszollá alakított fertőzésgátló, gyulladásgátló és vértolulást gátló szerek az orrmelléküreg-gyulladás kezelésében
IT1317904B1 (it) Formulazione farmaceutica di propionato di fluticasone.
CY1105607T1 (el) Η χρηση ενος η1 ανταγωνιστη και ριμεξαολης ως ενα ασφαλες στεροειδες για την θεραπεια ρινιτιδας
NO20013966D0 (no) Kombinasjoner for behandling av sykdommer som involverer angiogenese
AR020999A1 (es) Composiciones y proceso para la elaboracion de isotretinoina
TR200301613T2 (tr) Sapogenin türevleri, bunların sentezi ve kullanımı, bunların kullanım metotları.
EE200100136A (et) Atsetüülkoliini esteraasi inhibiitori ja psühhoosivastase toimeaine kasutamine ravimi valmistamiseks, mis on ette nähtud kognitsiooni- ja psühhoosihäirete raviks, ning neid aineid sisaldav farmatseutiline kompositsioon
DK279790A (da) Aromatiske steroid-5-alfa-reduktaseinhibitorer
PT1037604E (pt) Composicoes farmaceuticas de aerossol
DK0712311T3 (da) Antiglucocorticoidsteroider til behandling af angstlidelser
SE9604751D0 (sv) New therapy
NO20053626L (no) Blanding omfattende en kombinasjon av en aromataseinhibitor, et progestin og et ostrogen for anvendelse av behandling av endomeriose
IL164159A0 (en) C-17 spirolactonization and 6,7 oxidation of steroids
SE0300445D0 (sv) New combination
PE20011005A1 (es) Combinaciones de un inhibidor de fosfodiesterasa 4 y un antiinflamatorio esteroideo para el tratamiento de las enfermedades pulmonares
DE60229411D1 (de) Verfahren zur hemmung der verschlechterung der kognitiven leistungsfähigkeit bei erwachsenen mit down-syndrom
ATE419855T1 (de) Therapie für hormonersatz und depression enthaltend dienogest
ATE377020T1 (de) Kristallines gamma-lacton der17beta-hydroxy-
WO2004067022A3 (de) Verwendung eines neuropeptide und steroide enthaltenden gemisches zur behandlung von störungen des psychosozialen erlebens und verhaltens
WO2002019995A3 (en) Pharmaceutical combination containing salmeterol and fluticasone
AR020741A1 (es) Composicion y metodo para tratar enfermedades alergicas

Legal Events

Date Code Title Description
FX Voluntary withdrawal